Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 26, 2026 3.709
October 23, 2026 3.686
October 22, 2026 3.721
October 21, 2026 3.792
October 20, 2026 3.839
October 19, 2026 3.594
October 16, 2026 3.362
October 15, 2026 3.608
October 14, 2026 3.549
October 13, 2026 3.61
October 12, 2026 3.766
October 09, 2026 3.926
October 08, 2026 3.862
October 07, 2026 3.768
October 06, 2026 3.634
October 05, 2026 3.643
October 02, 2026 3.586
October 01, 2026 3.733
September 30, 2026 3.801
September 29, 2026 3.825
September 28, 2026 3.855
September 25, 2026 3.782
September 24, 2026 3.896
September 23, 2026 3.829
September 22, 2026 4.044
Date Value
September 21, 2026 4.039
September 18, 2026 4.037
September 17, 2026 4.261
September 16, 2026 4.083
September 15, 2026 4.224
September 14, 2026 4.370
September 11, 2026 4.297
September 10, 2026 4.346
September 09, 2026 4.528
September 08, 2026 4.792
September 04, 2026 5.729
September 03, 2026 5.887
September 02, 2026 5.932
September 01, 2026 5.922
August 31, 2026 6.000
August 28, 2026 5.915
August 27, 2026 6.156
August 26, 2026 6.220
August 25, 2026 6.215
August 24, 2026 6.132
August 21, 2026 6.158
August 20, 2026 6.130
August 19, 2026 6.319
August 18, 2026 6.135
August 17, 2026 6.17

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.63
Anika Therapeutics, Inc. 2.085
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.112

Price to Book Value Related Metrics

Price 16.61
Earnings Yield -20.06%
Market Cap 2.752B